Souvien Therapeutics Company
Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.
Investors Number:
1
Headquarters:
Salt Lake City, Utah, United States
Last Funding Date:
2019
Technology:
Anti-infective Drugs
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Total Funding:
3500000
Industry:
Biotechnology, Pharmaceutical